Abstract
A multicenter randomized and balanced double-blind trial with the objective of assessing the efficacy and tolerance of nimorazole given as a hypoxic radiosensitizer in conjunction with primary radiotherapy of invasive carcinoma of the supraglottic larynx and pharynx.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology |
Vol/bind | 46 |
Udgave nummer | 2 |
Sider (fra-til) | 135-46 |
Antal sider | 12 |
Status | Udgivet - 1 feb. 1998 |